Alliança Saúde e Participações S.A. (BVMF:AALR3)
6.85
+0.01 (0.15%)
Apr 2, 2025, 4:45 PM GMT-3
BVMF:AALR3 Balance Sheet
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 114.97 | 218.6 | 218.74 | 127.31 | 229.09 | Upgrade
|
Trading Asset Securities | - | - | 1.69 | - | - | Upgrade
|
Cash & Short-Term Investments | 114.97 | 218.6 | 220.43 | 127.31 | 229.09 | Upgrade
|
Cash Growth | -47.40% | -0.83% | 73.15% | -44.43% | 159.44% | Upgrade
|
Accounts Receivable | 447.14 | 202.16 | 186.22 | 254.28 | 242.58 | Upgrade
|
Other Receivables | 73.56 | 75.48 | 47.77 | 55.87 | 46.11 | Upgrade
|
Receivables | 520.69 | 277.64 | 233.99 | 310.15 | 288.68 | Upgrade
|
Inventory | 11.62 | 12.26 | 14.63 | 11.63 | 10.01 | Upgrade
|
Other Current Assets | 47.15 | 16.25 | 15.24 | 40.2 | 41.16 | Upgrade
|
Total Current Assets | 694.43 | 524.75 | 484.28 | 489.29 | 568.93 | Upgrade
|
Property, Plant & Equipment | 803.72 | 786.66 | 811.02 | 792.95 | 726.99 | Upgrade
|
Long-Term Investments | 2.72 | 7.66 | 7.2 | 7.2 | 12.18 | Upgrade
|
Goodwill | - | 844.77 | 844.77 | 844.77 | 844.77 | Upgrade
|
Other Intangible Assets | 1,036 | 215.74 | 212.62 | 191.11 | 188.74 | Upgrade
|
Long-Term Deferred Tax Assets | 209.61 | 204.32 | 205.23 | 165.86 | 137.89 | Upgrade
|
Other Long-Term Assets | 143.18 | 85.92 | 50.34 | 51.06 | 61.11 | Upgrade
|
Total Assets | 2,889 | 2,670 | 2,615 | 2,542 | 2,541 | Upgrade
|
Accounts Payable | 78.42 | 128.86 | 94.18 | 75.4 | 80.43 | Upgrade
|
Accrued Expenses | 118.58 | 104.32 | 69.59 | 43.76 | 41.15 | Upgrade
|
Current Portion of Long-Term Debt | 293.99 | 375.98 | 424.49 | 366.56 | 262.98 | Upgrade
|
Current Portion of Leases | 12.87 | 31.06 | 33.79 | 30.4 | 39.63 | Upgrade
|
Current Income Taxes Payable | 144.38 | 71.7 | 34.22 | 27.73 | 25.99 | Upgrade
|
Other Current Liabilities | 18.16 | 22.91 | 22.13 | 45.68 | 26.3 | Upgrade
|
Total Current Liabilities | 666.4 | 734.82 | 678.39 | 589.53 | 476.48 | Upgrade
|
Long-Term Debt | 427.72 | 669.24 | 608.9 | 411.43 | 517.1 | Upgrade
|
Long-Term Leases | 216.48 | 232.97 | 268.05 | 263.04 | 225.96 | Upgrade
|
Long-Term Deferred Tax Liabilities | 6.05 | 7.5 | 17.33 | 14.96 | 16.83 | Upgrade
|
Other Long-Term Liabilities | 435.75 | 81.3 | 60.87 | 53.84 | 80.56 | Upgrade
|
Total Liabilities | 1,752 | 1,726 | 1,634 | 1,333 | 1,317 | Upgrade
|
Common Stock | 612.41 | 612.41 | 612.41 | 612.41 | 612.41 | Upgrade
|
Retained Earnings | -634.97 | -505.86 | -277.98 | -50.17 | -44.54 | Upgrade
|
Treasury Stock | -1.9 | -2.28 | -5.45 | -7.5 | -0.28 | Upgrade
|
Comprehensive Income & Other | 1,119 | 813.18 | 620.71 | 620.54 | 622.94 | Upgrade
|
Total Common Equity | 1,095 | 917.46 | 949.7 | 1,175 | 1,191 | Upgrade
|
Minority Interest | 42.02 | 26.54 | 32.22 | 34.14 | 33.15 | Upgrade
|
Shareholders' Equity | 1,137 | 943.99 | 981.92 | 1,209 | 1,224 | Upgrade
|
Total Liabilities & Equity | 2,889 | 2,670 | 2,615 | 2,542 | 2,541 | Upgrade
|
Total Debt | 951.06 | 1,309 | 1,335 | 1,071 | 1,046 | Upgrade
|
Net Cash (Debt) | -836.09 | -1,091 | -1,115 | -944.12 | -816.58 | Upgrade
|
Net Cash Per Share | -7.07 | -9.22 | -9.46 | -8.06 | -6.92 | Upgrade
|
Filing Date Shares Outstanding | 119.57 | 118.08 | 117.81 | 117.7 | 118.27 | Upgrade
|
Total Common Shares Outstanding | 119.57 | 118.08 | 117.81 | 117.7 | 118.27 | Upgrade
|
Working Capital | 28.03 | -210.07 | -194.11 | -100.24 | 92.45 | Upgrade
|
Book Value Per Share | 9.16 | 7.77 | 8.06 | 9.99 | 10.07 | Upgrade
|
Tangible Book Value | 59.23 | -143.05 | -107.69 | 139.42 | 157.03 | Upgrade
|
Tangible Book Value Per Share | 0.50 | -1.21 | -0.91 | 1.18 | 1.33 | Upgrade
|
Machinery | - | 936.71 | - | - | - | Upgrade
|
Leasehold Improvements | - | 228.96 | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.